Canada and UK backs AstraZeneca’s Covid-19 vaccine
On Thursday, Canada`s health department joined the European counterparts for backing AstraZeneca COVID-19 vaccine and said that they do not lead to overall increase in blood clots.
Five cases of a rare brain blood clot among 11 million administered shots were found.
“Health Canada confirms that the benefits of the AstraZeneca COVID-19 vaccine in protecting Canadians from COVID-19 continue to outweigh the risks,” the regulator said in a statement.
“To date in Canada, there has been one report of a stroke that occurred in an individual following vaccination,” the regulator said.
“This case has been assessed by Health Canada and determined not to be related to the vaccine.”
When the use of vaccine was to be suspended by dozen countries after blood clots, European Union said that the vaccine was safe and effective and British regulators said its use should continue.
“The Oxford jab is safe and the Pfizer jab is safe. The thing that isn’t safe is catching COVID which is why it’s so important that we all get our jabs as soon as our turn comes,” British Prime Minister Boris Johnson said.
June Raine, Chief Executive of the UK’s MHRA, said there was “no evidence that blood clots in veins is occurring more than would be expected in the absence of vaccination, for either vaccine.”
“Given the extremely rare rate of occurrence of these CSVT events among the 11 million people vaccinated (with AstraZeneca), and as a link to the vaccine is unproven, the benefits of the vaccine in preventing COVID-19, with its associated risk of hospitalisation and death, continue to outweigh the risks of potential side effects,” she said.
The use of vaccine has been resumed by Germany, France and European nations.
The Health Canada said that the shot was not associate with an increase in overall risk of blood clots.
The country is using AstraZeneca doses made at the Serum Institute of India. It has received 500,000 doses and expects to get 1.5 million more by May.